« TB diagnosis change causes confusion | Main | Concerts aim to save the Earth »

New candidate drug for bipolar disorder

A designed alternative to lithium shows early promise.

A potential new drug for treatment of bipolar disorder (sometimes called manic depression) is being designed by researchers in Chicago and New York. The team hopes that their compound, which works as well in mice as do the currently prescribed drugs, will ultimately provide relief without the side-effects of present treatments.

Read the story here.

Posted by Nicola Jones on July 6, 2007 06:03 PM |

TrackBack

TrackBack URL for this entry:
http://blogs.nature.com/cgi-bin/mt/mt-tb.cgi/2987

Comments

I hope this is succesful. Having a daughter who is dealing with this disorder and seeing the side effects of her medicines causing problems that are unwanted makes me want to be able to try this new drug. But I know we need to go through the testing to prove no other problems. I wish the researchers the best in doing their work.

Ray

Posted by: Ray Thorp | July 9, 2007 03:19 PM

I believe that the sentence "They also altered the enzyme so that it could get from the blood into the brain", should read "They also altered the compound so that it could get from the blood into the brain".

Posted by: Hidevaldo B. Machado | July 9, 2007 10:00 PM

Post a comment

Comments will be reviewed by staff before being published. You can be as critical or controversial as you like, but please don't get personal or offensive, and do keep it brief. Excessively long entries may be cropped. Remember this is for feedback and discussion - not for publishing papers or press releases.

We strongly encourage you to use your real, full name. Email addresses are required: this is just in case we need to discuss your comment with you privately. They won’t be published.


Please enter the numbers you see below - this helps us to cut down on spam. Note that attempting to post within 30 seconds of hitting ‘preview’ or ‘post’ can cause the system to think you are spamming the site. If you are having trouble with this system, you can instead e-mail a comment to 'inthefield at nature.com'.

Search